“I think some of the new treatments will probably move the needle a little bit more in terms of treating this indication.” Ip MS. Update on the current treatment of diabetic retinopath ...

Arogya Aarohan app & other AI-driven tools are being tested for early detection of diseases as part of Rs 300-cr initiative ...

The impact of this programme over two decades has been considerable—it has facilitated early diagnosis and prompt treatment for both proliferative diabetic retinopathy and diabetic macular oedema; ...

A recent cohort study revealed low adoption of FDA-approved AI-based diabetic retinopathy detection, with less than 5% of diabetic patients receiving ophthalmic imaging. Researchers emphasize the need ...

These fragile new vessels leak fluid that collects ... until significant damage occurs. What are the treatment options available for diabetic retinopathy? Early stages may only require ongoing ...

US-based biotechnology company Ocugen has dosed the first subject in a multicentre Phase I trial of OCU200 for diabetic ...

HealthDay News — Empagliflozin initiation is not associated with incident nonproliferative diabetic retinopathy (NPDR) compared with initiation of a dipeptidyl ... The researchers found that during a ...

People with type 2 diabetes who are taking empagliflozin are less likely to develop diabetic retinopathy compared to those not using the drug, new evidence has revealed. A recent study from the ...

Regillo discussed treatment with panretinal photocoagulation ... When to initiate therapy for proliferative diabetic retinopathy. Presented at: OSN New York and OSN New York Retina; Nov.

Laser treatment was considered to be indicated in seven people for maculopathy, and in two for proliferative changes. In four people the visual acuity was reduced to a low vision level as a result of ...